These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4629559)

  • 61. Large scale preparation of S-carboxymethylated chains of human fibrin and fibrinogen and the occurrence of -chain variants.
    Henschen A; Edman P
    Biochim Biophys Acta; 1972 Apr; 263(2):351-67. PubMed ID: 5031163
    [No Abstract]   [Full Text] [Related]  

  • 62. The human fibrin-stabilizing factors.
    Bohn H
    Mol Cell Biochem; 1978 Jun; 20(2):67-75. PubMed ID: 353534
    [No Abstract]   [Full Text] [Related]  

  • 63. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking.
    Achyuthan KE; Dobson JV; Greenberg CS
    Biochim Biophys Acta; 1986 Aug; 872(3):261-8. PubMed ID: 2873839
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The fibrin-stabilizing factor. A decade of progress.
    Mandel EE
    Ann Clin Lab Sci (1971); 1971; 1(1):92-9. PubMed ID: 4949766
    [No Abstract]   [Full Text] [Related]  

  • 65. Determination of factor XIII activity and of factor XIII inhibitors using an ammonium-sensitive electrode.
    Hellstern P; Schilz K; von Blohn G; Wenzel E
    Thromb Haemost; 1983 Aug; 50(2):563-6. PubMed ID: 6138878
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Possible cross-linking of factor VIII related antigen to fibrin by factor XIII in delayed coagulation process.
    Hada M; Kato M; Ikematsu S; Fujimaki M; Fukutake K
    Thromb Res; 1982 Jan 1-15; 25(1-2):163-8. PubMed ID: 6801810
    [No Abstract]   [Full Text] [Related]  

  • 67. Factor XIII-deficiency in the blood of venous leg ulcer patients.
    Vanscheidt W; Hasler K; Wokalek H; Niedner R; Schöpf E
    Acta Derm Venereol; 1991; 71(1):55-7. PubMed ID: 1676216
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Electrophoretic studies on fibrinogen subunits and factor-XIII+-stabilized fibrin, from normal and cobalt-treated rabbits].
    Krantz S; Lober M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 100(3):295-302. PubMed ID: 4130627
    [No Abstract]   [Full Text] [Related]  

  • 69. The fibrin stabilizing factor, factor XIII.
    Duckert F
    Blut; 1973 Mar; 26(3):177-9. PubMed ID: 4571301
    [No Abstract]   [Full Text] [Related]  

  • 70. A comparative study of crosslinked and noncrosslinked fibrin from the major classes of vertebrates.
    Schwartz ML; Pizzo SV; Sullivan JB; Hill RL; McKee PA
    Thromb Diath Haemorrh; 1973 May; 29(2):313-38. PubMed ID: 4762256
    [No Abstract]   [Full Text] [Related]  

  • 71. Coagulation factor XIII: a multifunctional transglutaminase with clinical potential in a range of conditions.
    Dickneite G; Herwald H; Korte W; Allanore Y; Denton CP; Matucci Cerinic M
    Thromb Haemost; 2015 Apr; 113(4):686-97. PubMed ID: 25652913
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cross-linking of fibrinogen and fibrin by fibrin-stablizing factor (factor XIIIa).
    Kanaide H; Shainoff JR
    J Lab Clin Med; 1975 Apr; 85(4):574-97. PubMed ID: 1168234
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Molecular structure of fibrin stabilizing factors in man. II. Comparative immunologic studies on factor XIII deficient plasma and normal plasma].
    Bohn H; Becker W; Trobisch H
    Blut; 1973 May; 26(5):303-11. PubMed ID: 4122681
    [No Abstract]   [Full Text] [Related]  

  • 74. Autoimmune antibody in a hemorrhagic patient interacts with thrombin-activated factor XIII in a unique manner.
    Lorand L; Velasco PT; Murthy SN; Lefebvre P; Green D
    Blood; 1999 Feb; 93(3):909-17. PubMed ID: 9920840
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Formation of soluble fibrin complexes and some factors affecting their solubility.
    Wegrzynowicz Z; Kopeć M; Latallo ZS
    Scand J Haematol Suppl; 1971; 13():49-59. PubMed ID: 5290703
    [No Abstract]   [Full Text] [Related]  

  • 76. Characterization of fibrinogen and fibrin degradation products by isoelectric focusing in polyacrylamide gel.
    Arnesen H
    Thromb Res; 1974 Jun; 4(6):861-8. PubMed ID: 4844064
    [No Abstract]   [Full Text] [Related]  

  • 77. Gel electrophoresis for assessing fibrin crosslinking: a precaution.
    Finlayson JS; Morton RO
    Clin Chim Acta; 1972 Jan; 36(1):254-6. PubMed ID: 4621428
    [No Abstract]   [Full Text] [Related]  

  • 78. Fibrin digestion by thrombin. Comparison with plasmin-digested fibrinogen.
    Kang EP; Triantaphyllopoulos DC
    Biochim Biophys Acta; 1977 Feb; 490(2):430-42. PubMed ID: 138448
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The epsilon-(gamma-glutamyl)lysine crosslink and the catalytic role of transglutaminases.
    Folk JE; Finlayson JS
    Adv Protein Chem; 1977; 31():1-133. PubMed ID: 73346
    [No Abstract]   [Full Text] [Related]  

  • 80. Hereditary aspects of fibrin cross-linking.
    Hampton JW; Garrison D; Morton RO; Bannerjee D
    Ann N Y Acad Sci; 1972 Dec; 202():204-12. PubMed ID: 4629551
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.